Real-life treatment persistence and treatment outcomes of Finnish patients with inflammatory bowel disease receiving vedolizumab as first-line biological treatment
PMID: 38975101
Source: Heliyon
Publication date:
2025-07-24
Year:
2024
Abstract
NULL